| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 316,164 | 187,116 | 184,734 | 239,058 | | Cost of Revenue | 289,628 | 161,403 | 147,832 | 201,856 | | | Gross Profit | 26,536 | 25,713 | 36,902 | 37,202 | | | Operating Expenses | | Research Development | 4,239 | 4,892 | 4,605 | 4,054 | | Selling General and Administrative | 19,196 | 20,172 | 20,851 | 19,983 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,101 | 649 | 11,446 | 13,165 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 252 | (133) | (62) | 52 | | Earnings Before Interest And Taxes | 3,274 | 516 | 11,384 | 13,217 | | Interest Expense | (33) | (103) | 136 | 107 | | Income Before Tax | 3,307 | 619 | 11,248 | 13,110 | | Income Tax Expense | 88 | 178 | 3,872 | 1,402 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,219 | 441 | 7,376 | 11,708 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,219 | 441 | 7,376 | 11,708 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,219 | $441 | $7,376 | $11,708 |
|
0.02% Nasdaq 
0.33%
Income Statement
